Concepedia

Publication | Open Access

Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma

DOIFull Paper Access

45

Citations

36

References

2020

Year

Mu‐Chen Zhang, Ying Fang, Li Wang, Shu Cheng, Di Fu, Yang He, Yan Zhao, Chao‐Fu Wang, Xufeng Jiang, Qi Song,
Clinical Epigenetics

Abstract

CR-CHOP is effective and safe in elderly patients with newly diagnosed DLBCL. Relevance of DEL phenotype and molecular biomarkers on CR-CHOP response warrants further investigation in DLBCL. Trial registration ClinicalTrial.gov, NCT02753647. Registered on April 28, 2016.

References

YearCitations

Page 1